Ukraine has a high rate of hepatitis C, with estimated 3.6 per cent of the population living with the disease while the average rate in Europe is estimated to be 1.5 per cent. Mykolaiv region, southern Ukraine, is one of the most affected. It registers also high rates of HIV and co-infection HIV-Hepatitis C. From December 2017 to May 2020, MSF supported the health authorities in piloting a programme to implement generic drugs in the country. The combination of affordable daclatasvir and sofosbuvir drugs reduced the time of treatment from 24-72 weeks to 12-24 weeks. It showed less side effects and increased the cure rate from 50 to almost 94 per cent. MSF provided tests, medications, laboratory equipment and supplies. The organisation also conducted over 7,200 health education and counselling sessions to support people to cope with the stigma and emotional challenges they face. This web clip highlights the main outcomes by the time we are fully handing over the activities to local health authorities.